Literature DB >> 25818505

Cytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia function.

Michael Koldehoff1, Monika Lindemann2, Bertram Opalka3, Sebastian Bauer4, Rudolf Stefan Ross5, Ahmet H Elmaagacli1,6.   

Abstract

Cytomegalovirus (HCMV) reactivation occurs frequently after hematopoietic stem cell transplantation and is associated with an increased treatment-related mortality. Induction of apoptosis by HCMV is unusual because HCMV utilizes various strategies to prevent apoptosis in infected cells in order to delay cell death and maintain viral replication. Here we show that HCMV can infect the acute leukemia cell lines Kasumi-1 (AML) and SD-1 (BCR-ABL-positive ALL), which inhibited their proliferation and induced apoptosis in almost all cells after 14 days. Although HCMV induced a significant up-regulation of the anti-apoptotic gene cFLIP and the anti-stress gene Gadd45a, and simultaneously down-regulated the pro-apoptotic genes p53, Gadd45gamma in Kasumi-1 and SD-1 cells, we found that these anti-apoptotic mechanisms failed in HCMV-infected acute leukemia cells and apoptosis occurred via a caspase-dependent pathway. We conclude that HCMV can provide anti-leukemic effects in vitro. To determine if this phenomenon may be clinically relevant further investigations will be required.

Entities:  

Keywords:  Acute leukemia; HCMV; transplant

Mesh:

Substances:

Year:  2015        PMID: 25818505     DOI: 10.3109/10428194.2015.1032968

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  16 in total

1.  Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression.

Authors:  Dan A Erkes; Corinne J Smith; Nicole A Wilski; Sofia Caldeira-Dantas; Toktam Mohgbeli; Christopher M Snyder
Journal:  J Immunol       Date:  2017-02-15       Impact factor: 5.422

2.  Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response.

Authors:  Sarah Guenounou; Cécile Borel; Emilie Bérard; Edwige Yon; Marylise Fort; Catherine Mengelle; Sarah Bertoli; Audrey Sarry; Suzanne Tavitian; Françoise Huguet; Michel Attal; Christian Récher; Anne Huynh
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 3.  Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis.

Authors:  Shimaa Hassan AbdelAziz Soliman; Arturo Orlacchio; Fabio Verginelli
Journal:  Microorganisms       Date:  2021-05-30

Review 4.  Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation.

Authors:  Ahmed Gaballa; Faisal Alagrafi; Michael Uhlin; Arwen Stikvoort
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

5.  The cytomegalovirus protein UL138 induces apoptosis of gastric cancer cells by binding to heat shock protein 70.

Authors:  Wenjing Chen; Kezhi Lin; Liang Zhang; Gangqiang Guo; Xiangwei Sun; Jing Chen; Lulu Ye; Sisi Ye; Chenchen Mao; Jianfeng Xu; Lifang Zhang; Lubin Jiang; Xian Shen; Xiangyang Xue
Journal:  Oncotarget       Date:  2016-02-02

6.  Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.

Authors:  Amit Kumar; Laurie Coquard; Sébastien Pasquereau; Laetitia Russo; Séverine Valmary-Degano; Christophe Borg; Pierre Pothier; Georges Herbein
Journal:  Mol Ther Oncolytics       Date:  2016-04-27       Impact factor: 7.200

7.  Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.

Authors:  Michael Koldehoff; Monika Lindemann; Stefan R Ross; Ahmet H Elmaagacli
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

Review 8.  Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.

Authors:  Nicolle H R Litjens; Lotte van der Wagen; Jurgen Kuball; Jaap Kwekkeboom
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

Review 9.  The Human Cytomegalovirus, from Oncomodulation to Oncogenesis.

Authors:  Georges Herbein
Journal:  Viruses       Date:  2018-08-03       Impact factor: 5.048

Review 10.  Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?

Authors:  Georges Herbein; Zeina Nehme
Journal:  Mol Ther Oncolytics       Date:  2020-03-29       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.